The US Bankruptcy Court gave an order approving the sale of substantially all the assets of Lucira Health, Inc. on April 19, 2023. The debtor has been authorized to sell substantially all its assets to Pfizer Inc. for a consideration consisting of the assumed liabilities, $5 million in cash plus the payments of cure cost plus an additional cash payment of $7 million less the aggregate amount of paid cure costs associated with the Jabil contracts and any transition contracts, if any.